-
A next-generation drug tested in yeast was found to extend lifespan and slow aging by influencing a major growth-control pathway. Researchers also uncovered an unexpected role for agmatinases, enzymes that help keep this pathway in balance. Diet and gut microbes may affect aging more than expected because they produce the metabolites involved.
-
Regular consumption of polyphenol-rich foods like tea, coffee, berries, nuts, and whole grains may significantly support long-term heart health. A decade-long study of more than 3,100 adults found that those who consistently ate polyphenol-packed diets had healthier blood pressure and cholesterol levels, as well as lower predicted cardiovascular risk.
-
A researcher from the University of Tokyo and a U.S.-based structural engineer developed a new computational form-finding method that could change how architects and engineers design lightweight and free-form structures covering large spaces. The technique specifically helps create gridshells, thin, curved surfaces whose members form a networked grid. The method makes use of NURBS surfaces, a widely used surface representation format in computer-aided design (CAD). It also drastically reduces computation cost — a task that previously took 90 hours on a high-end GPU completes in about 90 minutes on a standard CPU.
-
Cedars-Sinai scientists have created a new experimental drug called TY1 that helps the body repair damaged DNA and restore injured tissue. The discovery came from studying tiny molecular messages released by heart cells that naturally support healing after injury. By identifying and recreating the most powerful of these messages, the team developed a synthetic RNA molecule that boosts the body’s DNA-repair system, reduces scarring, and may improve recovery after heart attacks and other diseases.
-
A large study found that people with impaired kidneys tend to have higher Alzheimer’s biomarkers, yet they don’t face a higher overall risk of dementia. For those who already have elevated biomarkers, kidney problems may speed up when symptoms appear. The findings show that kidney health can change how Alzheimer’s blood tests are read. Doctors may need to consider both organs to get a clearer picture.